All In Biotech

Drug Trial Radar · NCT06532253

Long-term Safety Trial with NVDX3

Long-term Safety Bucket Trial with NVDX3, an Osteogenic Implant of Human Allogenic Origin.

Last checked: Nov 19, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Aug 22, 2024

Primary completion

Mar 2036

Study completion Mar 2036

Sponsor

Lead sponsor
Novadip BiosciencesIndustry
Sponsor type
Industry
Collaborators
PrimeVigilance; Data Investigation Company Europe (DICE)
First posted
Aug 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An study evaluating the long-term safety of all patients previously treated with NVDX3.

Conditions

  • Distal Radius Fractures
  • Degenerative Lumbar Spondylolisthesis

Interventions

  • NVDX3Drug

    NVDX3 is implanted during a single surgical intervention, that took place in the core trials (refer to NCT05961956 and NCT05987033)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-term safety of the NVDX3 implantTime frame: Between screening (V0) and 120 months post-core study (V10)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier de Luxembourg

    Luxembourg, Luxembourg · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.